Meet our Associate Editor, Xiaoxuan Liu

We are delighted to introduce you to our new RSC Pharmaceutics Associate Editor, Professor Xiaoxuan Liu.

Professor Xiaoxuan Liu is a Professor at the Center of Advanced Pharmaceuticals and Biomaterials in China Pharmaceutical University. Her research interest focuses on the development of novel dendrimer based nanosystems via modular self-assembling process for on-demand delivery of drugs and nucleic acid therapeutics in precision medicine.

Read more about Professor Liu here.

 

Read some of Professor Liu’s research here:

Cargo-selective and adaptive delivery of nucleic acid therapeutics by bola-amphiphilic dendrimers
Jiaxuan Chen, Dandan Zhu, Baoping Lian, Kangjie Shi, Peng Chen, Ying Li, Wenyi Lin, Ling Ding, Qiulin Long, Yang Wang, Erik Laurini, Wenjun Lan, Yun Li, Aura Tintaru, Caoyun Ju, Can Zhang, Sabrina Pricl, Juan Iovanna, Xiaoxuan Liu and Ling Peng
Proc. Natl. Acad. Sci. U.S.A., 2023, 120, e2220787120

A biodegradable amppnas.org/doi/10.1073/pnas.2220787120hiphilic poly(aminoester) dendrimer for safe and effective siRNA delivery
Chi Ma, Dandan Zhu, Wenyi Lin, Ying Li, Yuanzheng Huang, Huiling Zhu, Mengyun Ye, Yang Wang, Ling Peng and Xiaoxuan Liu
Chem. Commun., 2022, 58, 4168-4171

An amphiphilic dendrimer as a light-activable immunological adjuvant for in situ cancer vaccination
Yongchao Wang, Ningqiang Gong, Chi Ma, Yuxuan Zhang, Hong Tan, Guangchao Qing, Jimei Zhang, Yufei Wang, Jinjin Wang, Shizhu Chen, Xianlei Li, Qiankun Ni, Yuan Yuan, Yaling Gan, Junge Chen, Fangzhou Li, Jinchao Zhang, Caiwen Ou, Yongxiang Zhao, Xiaoxuan Liu and Xing-Jie Liang
Nat. Commun., 2021, 12, 4964

RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is now open for submissions.

Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.

Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.

Meet our Associate Editor, Clare Hoskins

We are delighted to introduce you to our RSC Pharmaceutics Associate Editor, Professor Clare Hoskins.

Professor Clare Hoskins is a Professor of Nanomedicine within the Department of Pure and Applied Chemistry, University of Strathclyde. Her research focusses on the development of various nanotechnology platforms for drug delivery and theranostics, with a special focus on cancer nanomedicine.

You can find out more about Professor Hoskins here.

RSC Pharmaceutics is a new gold open access journal leading the way in the field of Pharmaceutics. This journal publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. Read our full scope statement and submit your manuscript on our webpage.

Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.

Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.

RSC Pharmaceutics is now open for submissions

 

RSC Pharmaceutics is now open for submissions.

 

If you are working on pioneering research in pharmaceutics, such as drug delivery, precision medicine and enhanced drug targeting, then this is the journal for you.

 

RSC Pharmaceutics research has the potential to drive change in worldwide health. As a not-for-profit society publisher, we are active scientists who work together to amplify the global impact of everyone who publishes with us. We are also waiving all article processing charges for this journal until mid-2026 – so you can publish and read for free.

 

We can’t wait to discover your next article. Learn more about our scope or start your submission now.

 

Introducing our RSC Pharmaceutics Editor-in-Chief

 

We are delighted to introduce you to Professor Yvonne Perrie, Editor-in-Chief of the new Royal Society of Chemistry journal RSC Pharmaceutics.

Yvonne Perrie is a Professor in Drug Delivery within the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Scotland. Professor Perrie’s research is multi-disciplinary and focuses on developing drug delivery systems to facilitate the delivery of drugs and vaccines, thus providing practical solutions for current healthcare problems. Read more on our webpage.

 

 

Read some of Professor Perrie’s research here:

The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency
Giulia Anderluzzi, Gustavo Lou, Stuart Woods, Signe Tandrup Schmidt, Simona Gallorini, Michela Brazzoli, Russell Johnson, Craig W. Roberts, Derek T. O’Hagan, Barbara C. Baudner and Yvonne Perrie
J. Control. Release, 2022, 342, 388-399

Mixing and flow-induced nanoprecipitation for morphology control of silk fibroin self-assembly
Saphia A. L. Matthew, Refaya Rezwan, Jirada Kaewchuchuen, Yvonne Perrie and F. Philipp Seib
RSC Adv., 2022, 12, 7357-7373

RSC Pharmaceutics is a new gold open access journal leading the way in the field of Pharmaceutics. This journal publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. Read our full scope statement on our webpage.

RSC Pharmaceutics opens for submissions later this year, sign up for e-alerts to be the first to find out news about the journal.

 

Introducing RSC Pharmaceutics

Placing pharmaceutics at the forefront of health solutions

RSC Pharmaceutics will be a place for you to explore and publish crucial research in pharmaceutics. This journal will harness the power of chemistry and related disciplines to build a healthier world for all.

You can expect compelling publications that cover emerging technologies and techniques in pharmaceutics, including drug delivery, precision medicine and enhanced drug targeting.

Find out more on our webpage.

 

Introducing our editor-in-chief

 

 

There are many exciting updates to come, including details on our editorial board and scope. Sign up for alerts to hear more.